Sartorius Stedim Biotech S.A. (SDMHF)
Market Closed
12 Jun, 20:00
$
205. 45
+3.88
+1.9249%
$
18.93B Market Cap
- P/E Ratio
0.49% Div Yield
3,400 Volume
- Eps
$ 201.57
Previous Close Want to track SDMHF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
SDMHF closed Friday higher at $205.45, an increase of 1.9249% from Thursday's close, completing a monthly increase of 13.5083% or $24.45. Over the past 12 months, SDMHF stock lost -16.4871%.
SDMHF pays dividends to its shareholders, with the most recent payment made on Apr 02, 2026. The next estimated payment will be in In 9 months on Apr 02, 2027 for a total of $0.81216.
The last earnings report, released on Apr 23, 2026, missed the consensus estimates by -1.21%. On average, the company has fell short of earnings expectations by -0.7277%, based on the last three reports.
Sartorius Stedim Biotech S.A. has completed 1 stock splits, with the recent split occurring on May 06, 2016.
The company's stock is traded on 11 different exchanges and in various currencies, with the primary listing on XPAR (EUR).
Sartorius Stedim Biotech S.A. (SDMHF) FAQ
What is the stock price today?
The current price is $205.45.
On which exchange is it traded?
Sartorius Stedim Biotech S.A. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is SDMHF.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.49%.
What is its market cap?
As of today, the market cap is 18.93B.
Has Sartorius Stedim Biotech S.A. ever had a stock split?
Sartorius Stedim Biotech S.A. had 1 splits and the recent split was on May 06, 2016.
Sartorius Stedim Biotech S.A. Profile
| Textiles, Apparel & Luxury Goods Industry | Consumer Discretionary Sector | Rene Faber CEO | OTC PINK Exchange | FR0013154002 ISIN |
| FR Country | 9,961 Employees | 31 Mar 2026 Last Dividend | 16 Jun 2005 Last Split | - IPO Date |
Overview
Sartorius Stedim Biotech S.A. is a cornerstone in the biopharmaceutical industry, providing a vast array of instruments and consumables used globally. The company's extensive product portfolio caters to the needs of medication manufacturers, food industries, chemical sectors, as well as research and development laboratories. Founded in 1870, with its headquarters in Aubagne, France, it stands as a subsidiary of Sartorius AG. Its offerings facilitate numerous critical processes in the biopharmaceutical production and development chain, from cell cultivation to the transportation of biological products.
Products and Services
- Cell Lines & Cell Culture Media: These foundational components are essential for the cultivation and maintenance of cells in the laboratory, enabling the growth of precise and replicable biological products.
- Bioreactors: Sartorius Stedim Biotech S.A. provides cutting-edge bioreactors that are integral for the cell cultivation process, facilitating the development of vaccines, enzymes, and other biotherapeutic agents.
- Separation, Purification, and Concentration Products: A comprehensive range of products designed for the critical stages of biopharmaceutical manufacturing, ensuring the purity and potency of the final products.
- Storage and Transportation Systems: Solutions for the safe handling, storage, and transportation of intermediate and finished biological products, addressing the challenges of maintaining product integrity.
- Service Offerings: The company extends its expertise through services in cell cultivation, fermentation, separation, purification, and fluid management, further supporting the biopharmaceutical production cycle.
- Batch and Intensified Chromatography Systems: These systems are tailored for smaller molecules, like oligonucleotides, peptides, and insulin, optimizing purification processes for efficiency and effectiveness.
- Recombinant Albumin-Based Solutions: Offering a safe and animal-free alternative for cell culture growth mediums, enhancing the productivity and reliability of biopharmaceutical products.
- Data Analytics Software: Advanced software solutions for modeling and optimizing the processes of biopharmaceutical development and production, empowering companies with data-driven insights for process improvement.
Contact Information
Address: Zone Industrielle Les Paluds
Phone: 33 4 42 84 56 00
Website: https://www.sartorius.com
